- Tytuł:
- CYP2C19 genotype-directed P2Y12inhibitor antiplatelet therapy normalizes risk for major adverse cardiovascular events after percutaneous coronary intervention
- Autorzy:
- Źródło:
- Indian Heart Journal; May-June 2021, Vol. 73 Issue: 3 p281-288, 8p
Periodyk